Outcomes reported in randomised trials of surgical prehabilitation: a scoping review

作者：Chloé Fleurent-Grégoire, Nicola Burgess, Linda Denehy, Lara Edbrooke, Dominique Engel, Giuseppe Dario Testa, Julio F. Fiore, Daniel I. McIsaac, Stéphanie Chevalier, John Moore, Michael P. W. Grocott, Robert Copeland, Denny Levett, Celena Scheede‐Bergdahl, Chelsia Gillis · 发表于：British Journal of Anaesthesia · 年份：2024 · DOI：10.1016/j.bja.2024.01.046 · 被引用次数：34 · 研究领域：Hip and Femur Fractures、Cerebral Palsy and Movement Disorders、Sports injuries and prevention

BACKGROUND: Heterogeneity of reported outcomes can impact the certainty of evidence for prehabilitation. The objective of this scoping review was to systematically map outcomes and assessment tools used in trials of surgical prehabilitation. METHODS: MEDLINE, EMBASE, PsychInfo, Web of Science, CINAHL, and Cochrane were searched in February 2023. Randomised controlled trials of unimodal or multimodal prehabilitation interventions (nutrition, exercise, psychological support) lasting at least 7 days in adults undergoing elective surgery were included. Reported outcomes were classified according to the International Society for Pharmacoeconomics and Outcomes Research framework. RESULTS: We included 76 trials, mostly focused on abdominal or orthopaedic surgeries. A total of 50 different outcomes were identified, measured using 184 outcome assessment tools. Observer-reported outcomes were collected in 86% of trials (n=65), with hospital length of stay being most common. Performance outcomes were reported in 80% of trials (n=61), most commonly as exercise capacity assessed by cardiopulmonary exercise testing. Clinician-reported outcomes were included in 78% (n=59) of trials and most frequently included postoperative complications with Clavien-Dindo classification. Patient-reported outcomes were reported in 76% (n=58) of trials, with health-related quality of life using the 36- or 12-Item Short Form Survey being most prevalent. Biomarker outcomes were reported in 16% of trials (n=12)...